JHS Svendgaard Laboratories Limited (NSE:JHS)

India flag India · Delayed Price · Currency is INR
11.45
-0.16 (-1.38%)
Sep 5, 2025, 3:29 PM IST
-1.38%
Market Cap980.17M
Revenue (ttm)945.23M
Net Income (ttm)-180.60M
Shares Out85.60M
EPS (ttm)-2.11
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume61,871
Average Volume203,526
Open11.87
Previous Close11.61
Day's Range11.30 - 11.87
52-Week Range10.02 - 32.69
Beta0.02
RSI49.17
Earnings DateAug 11, 2025

About NSE:JHS

JHS Svendgaard Laboratories Limited, together with its subsidiaries, manufactures, trades, and sells a range of oral and dental products for adults and kids in India. The company offers oral care products, such as toothbrushes, toothpastes, mouthwash products, hand sanitizers, laundry detergents, room fresheners, and denture tablet products under the Dr. Gold, Dr. Fresh, Boots, Lavoris, Peanuts, Amway, Dabur, Future Group, Apollo Pharmacy, Sandika Pharma, Elder Pharma, JL Morisons, Aquawhite, 6 Ten Store, Modi Care, Infectiguard, and Odonil bra... [Read more]

Founded 1997
Employees 250
Stock Exchange National Stock Exchange of India
Ticker Symbol JHS
Full Company Profile

Financial Performance

In 2024, NSE:JHS's revenue was 922.91 million, an increase of 26.61% compared to the previous year's 728.93 million. Losses were -197.44 million, 386.6% more than in 2023.

Financial Statements

News

JHS Svendgaard completes land acquisition in Jammu & Kashmir for business expansion; Stock drops 5%

JHS Svendgaard recently informed exchanges that it has acquired and completed the registration of sale deeds for the land of 18 Kanal 06 Marla in Hiranagar Kathua, Jammu & Kashmir, for the purpose of ...

1 year ago - Business Upturn